Comparison of therapeutic efficacy and safety of sitagliptin, dapagliflozin, or lobeglitazone adjunct therapy in patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea and metformin: Third agent study-Reference-Cited by-同舟云学术

Comparison of therapeutic efficacy and safety of sitagliptin, dapagliflozin, or lobeglitazone adjunct therapy in patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea and metformin: Third agent study

Published:2023-09 Issue: Volume:203 Page:110872
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Hong Jun Hwa,Moon Jun Sung,Seong Kayeon,Lim Soo^ORCID

Funder

Korean Diabetes Association

Seoul National University Bundang Hospital

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference34 articles.

1. Diabetes fact sheets in Korea, 2020: an appraisal of current status;Jung;Diabetes Metab J,2021

2. Deteriorating beta-cell function in type 2 diabetes: a long-term model;Bagust;QJM: An Int J Med,2003

3. 8. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2018;American;Diabetes Care,2018

4. 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2019;American;Diabetes Care,2019

5. Clinical implications of current cardiovascular outcome trials with sodium glucose cotransporter-2 (SGLT2) inhibitors;Lim;Atherosclerosis,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wastewater-based estimation of diabetes mellitus prevalence in 237 cities: A cross-China study;Science of The Total Environment;2024-05

2. Comparative efficacy of sodium glucose cotransporter-2 inhibitors in the management of type 2 diabetes mellitus: A real-world experience;World Journal of Diabetes;2024-03-15